News & Updates

Show Multimedia Only
Extended anticoagulation benefits cancer patients with distal DVT

Extended anticoagulation benefits cancer patients with distal DVT

20 Sep 2023 byAudrey Abella

In cancer patients with isolated distal deep vein thrombosis (IDDVT), a 12-month anticoagulation regimen with the oral factor Xa inhibitor edoxaban fared better than a 3-month regimen, findings from the ONCO DVT study have shown.

Extended anticoagulation benefits cancer patients with distal DVT

20 Sep 2023
Study confirms causal link between plasma cortisol and hypertension

Study confirms causal link between plasma cortisol and hypertension

18 Sep 2023